Ann: Letter to Shareholders, page-6

I respect that there are many who will applaud this letter however it doesn’t make me comfortable. It’s the second time in recent history. I don’t see it as giving me confidence but is more of a reflection of nervousness about the sp and the company. Sorry but a chair or MD who have confidence don’t need to send such letters especially where it restates what are basics with some window dressing adjectives. I remain confident in the company but would perhaps rather have a letter explaining the status of trials and anticipated ranges of result expectations if that is possible. That was done some time ago but not of late. Alternatively just have management hold firm without elaboration as analysts and commentators see this less positively. Just my view.